DiscoverESICM TalkInflammatory subphenotypes in patients at risk of ARDS: evidence from the LIPS-A trial
Inflammatory subphenotypes in patients at risk of ARDS: evidence from the LIPS-A trial

Inflammatory subphenotypes in patients at risk of ARDS: evidence from the LIPS-A trial

Update: 2024-05-08
Share

Description

Acute respiratory distress syndrome (ARDS) remains a life-threatening syndrome, resulting in high morbidity and mortality. In ARDS patients and mechanically ventilated critically ill patients, two distinct subphenotypes, presenting hyper- and non-hyperinflammatory characteristics, have been identified.

Studies show that early identification of the inflammatory subphenotypes in patients at risk of ARDS could serve as a predictive or prognostic strategy that will lead to an early intervention and individualization of care.

A study has been carried out to prove the hypothesis that the inflammatory subphenotypes are present before ARDS development in at-risk patients presenting to the emergency department and remain identifiable over time.

To learn more about the methods and findings of this study listen to the next podcast.

Comments 
In Channel
N&AHP – ICU diaries

N&AHP – ICU diaries

2024-05-2220:57

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Inflammatory subphenotypes in patients at risk of ARDS: evidence from the LIPS-A trial

Inflammatory subphenotypes in patients at risk of ARDS: evidence from the LIPS-A trial

ESICM